High-risk prostate cancer: value of multi-modality 3T MRI-guided biopsies after previous negative biopsies.
Transrectal ultrasound-guided biopsy is the gold standard for prostate cancer detection. The latter detection rates of random systematic TRUS-guided biopsy do not exceed 44%. As a consequence other biopsy methods have been explored. One of these methods is MR-guided biopsy (MRGB), which revealed detection rates of 38-59% after previous negative TRUSGB sessions. For this reason MRGB will probably become more and more applied in daily practice.
Department of Radiology (667), Radboud University Nijmegen Medical Centre, Geert Grooteplein 10, 6500 HB, Nijmegen, The Netherlands. J.Futterer@rad.umcn.nl
Jurgen J
JJ
Fütterer
Sadhna
S
Verma
Thomas
T
Hambrock
Derya
D
Yakar
Jelle O
JO
Barentsz
D001707:Biopsy, Needle / Q000379:methods*; D003287:Contrast Media; D006801:Humans; D053783:Magnetic Resonance Imaging, Interventional; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000473:pathology*
D003287:Contrast Media